The largest database of trusted experimental protocols

4 protocols using cd3 pc7

1

T cell Profiling and Exhaustion Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cell sub-population profiling studies on days 14 and 21 were analyzed using CD3-PC7 (Beckman Coulter, 6607100), CD4-APC-A700 (Beckman Coulter, B10824), CD8-PC5.5 (Beckman Coulter, B21205), EGFR-A488 (R&D Systems, FAB10951G), CD45RA-ECD (Beckman Coulter, IM2711U), CD45RO-PE (Miltenyi Biotech,130-113-559), CD27-APC-A750 (Beckman Coulter, B12701), and CD62L-APC (Miltenyi Biotech, 130-113-617) antibodies by Cytoflex Flow Cytometer analysis. Exhaustion profiling studies on days 14 and 21 were analyzed using CD3-PC7 (Beckman Coulter, 6607100), CD4-APC-A700 (Beckman Coulter, B10824), CD8-PC5.5 (Beckman Coulter, B21205), EGFR-A488 (R&D Systems, FAB10951G), CD279 (PD1)-PE (Miltenyi Biotech, 130-117-384), CD366 (TIM3)—APC (Invitrogen, Waltham, MA, USA, 17-3109-42), and CD223 (LAG-3)—APC-eFluor 780 (Invitrogen, 47-2239-42) antibodies by Cytoflex Flow Cytometer analysis.
+ Open protocol
+ Expand
2

In Vitro Assessment of CAR-T Cell Efficacy

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro studies with CAR-T cells (CD19-CD28z and CD19-BBz) were performed for the assessment of efficacy and cytotoxic capacity. For that purpose, anti-CD19-expressing CAR-T cells and CD19-expressing RAJI cells were cultured for 24 h, 7 days, and 14 days (CAR-T: RAJI; 1:1, 5:1, 10:1). Anti-cancer profiling studies on days 14 and 21 were analyzed using CD3-PC7 (Beckman Coulter, 6607100), CD4-APC-A700 (Beckman Coulter, B10824), CD8-PC5.5 (Beckman Coulter, B21205), EGFR-A488 (R&D Systems, FAB10951G), CD19-ECD (Beckman Coulter, A07770), CD25-APC (Miltenyi Biotech, 130-113-284), and CD107a (LAMP-1) -PE (Miltenyi Biotech, 130-111-621) by Cytoflex Flow Cytometer analysis. In the co-culture experiments, the death of CD19+ RAJI cells after 48 h and the CD25 activation (IL2RA, IL-2 receptor alpha chain) and CD107a (marker for degranulation of lymphocytes) cytotoxic de-granulation biomarkers of CAR-T cells and control T cells in CD3+ T cells were analyzed by flow cytometry. Survival analysis of CAR-T cells was performed to control the cell viability of RAJI cells and CAR-T cells. Trypan blue (Biological Industries, #03-102-1B) was applied to identify and count surviving cells. Cell counting and viability analysis were performed with the BIO-RAD TC20 Automated Cell Counter.
+ Open protocol
+ Expand
3

Generating and Staining pMHC Multimers

Check if the same lab product or an alternative is used in the 5 most similar protocols
pMHC monomers were generated as previously described66 (link). All pMHC-multimer reagents were generated by 45 min incubation of 4 μg biotinylated pMHC monomer with 1 μg streptavidin-BV421 (Biolegend, reference #405225) or Streptavidin-APC (eBioscience, reference #17-4317-82) in a total volume of 100 μl FACS buffer for staining of up to 1x107 cells. pMHC-multimer staining was performed separately from surface antibody staining for 45 min on ice. Surface antibody staining was performed for 25 min on ice subsequent to pMHC-multimer staining. Depending on the respective experiments, a subset of the following antibodies were used: anti-human TCR α/β FITC (BioLegend, reference #306706), CD3 PC7 (Beckman Coulter, reference #737657), CD8 PE (Invitrogen, reference #MHCD0804), anti-murine TCR β-chain APC (BioLegend, reference #109212), anti-murine TCR β-chain APC/Fire750 (BioLegend, reference #109246), CD62L FITC (Biolegend, reference #304804), CD45-RO PC7 (BioLegend, reference #304230), Lag3 FITC (Biolegend, reference #369308) and PD-1 APC (Invitrogen, reference #17-2799-42). Live/dead discrimination was performed with propidium iodide (LifeTechnologies, reference #P1304MP).
+ Open protocol
+ Expand
4

NK Cell Isolation and Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were taken from healthy adult volunteers who have given informed consent for their blood to be used in this study. Peripheral blood mononuclear cells (PBMC) were isolated by centrifugation on Ficoll density gradient 1.077 g/cm3 (Paneco, Russia). The NK cells were then magnetically separated using a human NK cell negative selection kit (Miltenyi Biotec, Germany). The percentage of CD3CD56+ cells in the preparations after separation was no less than 97% as verified by flow cytometry. In some cases, NK subpopulations were isolated from magnetically separated NK cells by fluorescent-activated cell sorting after staining with monoclonal antibodies CD3-PC7, CD56-APC (Beckman Coulter, USA), and CD57-FITC (eBioscience, USA). Isolated NK cells were cultivated in RPMI-1640 (Paneco) supplemented with 10% FCS (HyClone, USA) (200 μl) at cell concentration of 1.5·106 cells/ml or 0.5·106 cells/ml (for sorted cells) for 18 h in 96 U-well plates (Costar, USA). Recombinant human IL-2 (500 U/ml) purchased from Hoffmann-La-Roche (Germany) and LPS (5 μg/ml) from E. coli strain 055:B5 (Sigma-Aldrich, USA) were added to the cell culture. After incubation, TLR4 and CD69 expression and cytotoxicity of NK cells were analyzed; cell-free supernatants were collected for estimation of cytokine production.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!